This page shows the latest Q4 news and features for those working in and with pharma, biotech and healthcare.
Against the backdrop of the revision of the Pharmaceutical Legislation and the planned European Council Recommendations on AMR taking place in Q4 2022, the event brought together high-level European policymakers
The study, which will begin in Q4 2021, will build on the Drive Beyond the Needle collaboration between Enesi and the Biomedical Advanced Research and Development Authority (BARDA) earlier this year,
Regeneron will start to ship the extra doses immediately with the vast majority will be delivered in Q4.
The biotech will seek EMA approval for first-generation jab while trials are due to start for second-generation jabs in Q4.
initially allocated for Q3 and Q4 of 2021, and would be brought forward.
bluebird bio has posted a modest increase in its Q4 revenues and has also provided an update about its clinical hold on its sickle cell disease gene therapy LentiGlobin.
More from news
Approximately 18 fully matching, plus 120 partially matching documents found.
Taking a look at the Navigator365 ‘time- trends’ (EU5 SPEC, 2019 vs Q4 2020) we see that the online congress increased its reach by 37% (how often a physician has used
By Emma Eatwell
Yet, in Q4 2013, the coalition government announced that the yet to be launched National Liver Strategy was being scrapped.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
clinical data in Q4 2014.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
EU Pharmaceutical Strategy. But what does this mean and what can we expect to be included in the strategy that is anticipated for late Q4 2020 or early 2021?
both of which were established in Q4 2017.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...